NSIM
GMAB icon

North Star Investment Management’s Genmab GMAB Stock Holding History

North Star Investment Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.6K Buy
543
+283
+109% +$8.48K ﹤0.01% 956
2025
Q4 		$8.01K Buy
260
+217
+505% +$6.76K ﹤0.01% 1001
2025
Q3 		$1.32K Buy
+43
New +$1.05K ﹤0.01% 1150

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

North Star Investment Management's GMAB Position: Q1 2026 in Review

North Star Investment Management increased its Genmab (GMAB) stake by 109% in Q1 2026, buying an estimated $8.48K and bringing the position to 543 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #956.

North Star Investment Management first reported a position in GMAB in Q3 2025 and has held it in 3 quarters since. 273 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

  • North Star Investment Management held 543 shares of Genmab worth $14.6K as of Q1 2026.
  • North Star Investment Management bought 283 Genmab shares in Q1 2026, an estimated $8.48K.
  • Genmab made up ﹤0.01% of North Star Investment Management's portfolio in Q1 2026, its #956 holding.
  • North Star Investment Management first reported a position in Genmab in Q3 2025 and has held it in 3 quarters since.
  • 273 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on North Star Investment Management's 13F filing for Q1 2026, filed 23 Apr 2026.